Richard J. Barohn

Mutations in Kir2.1 Cause the Developmental and Episodic Electrical Phenotypes of Andersen's Syndrome

Nikki Plaster, Rabi Tawil, Martin Tristani‐Firouzi et al. · Cell · 2001 · 998 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

Randomized Trial of Thymectomy in Myasthenia Gravis

Gil I. Wolfe, Henry J. Kaminski, Inmaculada Aban et al. · New England Journal of Medicine · 2016 · 905 citations · Full text

Medicine, Endocrinology, Surgery +12

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

Medicine, Pharmacology, Pharmacotherapy +6

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

James F. Howard, Vera Bril, Tuan Vu et al. · The Lancet Neurology · 2021 · 668 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +4

Myasthenia gravis: recommendations for clinical research standards

Alfred Jaretzki, Richard J. Barohn, Raina M. Ernstoff et al. · The Annals of Thoracic Surgery · 2000 · 642 citations · Full text

Medicine, Neurology, Neuropathology +5